icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2020
Back grey_arrow_rt.gif
 
 
 
Excellent Efficacy and Safety of Sofosbuvir, Glecaprevir, Pibrentasvir and Ribavirin for Retreatment of Chronic Hepatitis C after Sofosbuvir, Velpatasvir and Voxilaprevir Failure
 
 
  AASLD 2021 Nov 12-15
 
Varun Saxena, MD MAS1,2; Jeff McKinney2; Scott L. Chamberland1; Lisa Catalli2; Suk I. Seo, MD1; Joanna B. Ready, MD1; Jennifer C. Price, MD PhD2 1Kaiser Permanente Northern California 2University of California San Francisco

1116211

1116212

1116213

1116214

1116215

1116216

1116217